PENTAX Medical Transfers C2 CryoBalloon Technology to Merit Medical Systems

Significant Transition in Healthcare Technology

On October 15, 2025, PENTAX Medical, a division of the renowned HOYA Group, took a pivotal step by announcing the sale of its C2 CryoBalloon™ product line to Merit Medical Systems, Inc. This strategic asset purchase agreement marks a significant shift for PENTAX Medical as it aims to sharpen its focus on its core competency in flexible reusable endoscopy.

The C2 CryoBalloon technology, which has been integrated into PENTAX Medical's therapeutic offerings since 2017, provides a minimally invasive solution for patients diagnosed with Barrett's Esophagus and various gastrointestinal disorders. This device employs controlled cryotherapy to eliminate unwanted tissue, ensuring the preservation of surrounding structures—an essential feature for patient safety and recovery.

With this transition, PENTAX Medical is optimistic about the future of the C2 CryoBalloon technology under Merit Medical's guidance. The company believes that Merit, recognized for its leadership in healthcare technology, will drive greater utilization and accessibility of the C2 platform—especially for patients contending with chronic gastroesophageal reflux disease (GERD) and related conditions.

Dominique Vincent, the President of PENTAX Medical, expressed pride in the clinical advancements achieved through the C2 technology. He highlighted that its value throughout their innovation journey has been impressive and that Merit Medical's extended expertise in therapeutic endoscopy positions them well to fully leverage the potential of the C2 CryoBalloon.

This strategic decision ensures that PENTAX Medical can refocus its resources and efforts on its primary strength: delivering flexible reusable endoscopy solutions. As the endoscopy sector continues to evolve, the company's intent is to keep providing user-friendly solutions that empower healthcare professionals to enhance patient care.

The integration of the C2 CryoBalloon technology into Merit Medical's existing endoscopy portfolio signifies an exciting development for the medical community. It complements Merit's diverse range of products while enriching their customer base. Over the coming months, the operational aspects will shift, including the relocation of product manufacturing to Merit’s facility situated in South Jordan, Utah. Such a move is anticipated to be seamless, supported by the transition of several PENTAX Medical employees joining the Merit team, ensuring continuity and bringing their invaluable expertise into the new structure.

PENTAX Medical, recognized for its superior quality in the endoscopy market, remains committed to providing exceptional products and services. Their mission intertwines product excellence with an understanding of clinical challenges, making them a reliable partner in the healthcare field, directly addressing the daily needs and workflows of clinicians.

Simultaneously, Merit Medical, founded in 1987, continues to thrive in developing proprietary medical devices vital for various therapeutic procedures. By focusing on interventional, diagnostic, and therapeutic solutions, Merit has built a reputable presence globally, with a workforce exceeding 7,300 individuals passionate about advancing healthcare technologies.

As the landscape of healthcare technology rapidly advances, partnerships like this one between PENTAX Medical and Merit Medical illuminate the path toward innovative solutions that can significantly enhance patient care. With a shared vision for improving healthcare outcomes, both companies are set to embark on a promising future that prioritizes the needs of patients and the effective delivery of care.